Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Janux Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing therapeutics based on its Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. Its focus is on developing a class of T cell engagers (TCEs). It is developing a broad pipeline with programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor...
All news about JANUX THERAPEUTICS, INC.
10/01 JANUX THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direc..
09/20 JANUX THERAPEUTICS, INC.(NASDAQGM : JANX) added to S&P TMI Index
09/09 JANUX THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
09/09 JANUX THERAPEUTICS : Appoints Ron Barrett, Ph.D., and Alana McNulty to Board of Directors
09/09 Janux Therapeutics, Inc. Announces Board Appointments
09/07 JANUX THERAPEUTICS : to Present Virtually at the H.C. Wainwright 23rd Annual Global Invest..
08/27 JANUX THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direc..
08/10 JANUX THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
08/10 JANUX THERAPEUTICS : Successful $222.9 million IPO in June brings total funds raised in th..
08/10 JANUX THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statem..
08/10 JANUX THERAPEUTICS : Reports Second Quarter 2021 Financial Results
08/10 Janux Therapeutics, Inc. Reports Unaudited Earnings Results for the Second Quarter and ..
07/19 JANUX THERAPEUTICS : Appoints Shahram Salek-Ardakani, Ph.D., Chief Scientific Officer
07/19 Janux Therapeutics Appoints Shahram Salek-Ardakani as Chief Scientific Officer of the C..
07/16 JANUX THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
News in other languages on JANUX THERAPEUTICS, INC.
- No features available -
Analyst Recommendations on JANUX THERAPEUTICS, INC.
Chart JANUX THERAPEUTICS, INC.
Technical analysis trends JANUX THERAPEUTICS, INC.
Short Term Mid-Term Long Term Trends Bearish Neutral Neutral
Number of Analysts
Last Close Price
Average target price
Spread / Average Target